Pre-clinical data from @DrDonWeaver’s group @UHN identified #furosemide, an already approved drug, as a potential therapy for severe #COVID–19. Next steps: a clinical study to test this in humans. Read more >> https://t.co/TYzr56uyTI @thePeerJ https://t.co/90kdgPQoNb https://t.co/C1yeS7E68K
Inhaled furosemide for COVID-19 https://t.co/z2i8dotjMg via @thePeerJ ... some encouraging work I have been doing with #Treventis founder @DrDonWeaver!
Pre-clinical data suggests the widely-used diuretic Furosemide may be repurposed as an inhaled therapy for patients with severe #Covid19 cases. @KrembilRI
Early results published in @thepeerj: https://t.co/yqRAddqzi0
Just published in #PeerJ - Small molecule therapeutics for #COVID-19: repurposing of inhaled furosemide https://t.co/xEbpk3OgJg
#CellBiology #immunology #infectiousdiseases https://t.co/GvPTivF2Cb